Grounding the scientific data into actionable insights for drug sponsors, the 5th NASH Summit is the outstanding forum and unrivalled platform for biotech and pharma to regroup, reassess and realign their NASH pipeline strategy. Uniting 100+ NASH experts from the EMA, Novartis, Gilead, Pfizer, Eli Lilly, Takeda, AstraZeneca, Merck, Janssen, Ionis, Novo Nordisk, the FDA and more, including […]

The only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications. This comprehensive, drug development focused agenda will showcase the latest concepts and molecular engineering approaches […]

Marrying unmissable insights from global renal experts, the 1st Rare & Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline. Hear from industry heavyweights including Sanofi Genzyme, Alexion, AstraZeneca, Regulus Therapeutics, Chinook […]

Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS. With 40+ expert leaders from the likes of Taysha Gene Therapies, Passage Bio, AskBio, Neurogene, Affinia Therapeutics and Alcyone […]

The 4th Commercializing Clinically Validated Digital Therapeutics Summit returns in December of 2021 as the only industry-led meeting deep-diving on stakeholder alliance and partnership to accelerate DTx scalability, to enable building sustainable & viable business models. DTx is happening, and happening fast on a global scale. The amount of investment continues to surge, and is […]

The 4th RNA-Targeted Drug Discovery Summit is returning once again this December, to reunite the largest community of thought leaders and experts in biology, chemistry and RNA therapeutics to discuss cutting-edge small molecule strategies capable of interacting with and modulating RNA with improved specificity, selectivity and drug-like properties. Join the leading RNA small molecule forum […]

Capitalize on the Scalable & Diverse Potential of iPSC-Derived Therapies By Defining Differentiation Protocols, Optimal Cell Line Selection & Optimizing Gene Engineering To Accelerate Successfully Into the Clinic The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing its place as the […]

Join us in Amsterdam from 7th – 8th December 2021 to find out more about why biotherapeutic products are progressing through clinics worldwide. As this trending topic gains more exposure and fast approaches commercialisation various challenges have presented themselves. Issues in areas such as key regulatory, manufacturing and supply chain are amongst some of the […]

TIGIT therapies have seen promising clinical validation, spearheading the next wave of Immune Checkpoint Inhibitors. As such there has been an explosion of interest and high-scale investment into this exciting space. Arriving at a critical point for TIGIT development, the 2nd Annual TIGIT Therapies Summit is the definitive industry-led event focused at propelling this next generation inhibitor to […]

Engineer 'Intelligent', Controllable Drugs at the First Technical Meeting Dedicated to Advancing the Therapeutic Applications of Synthetic Biology This year, the synthetic biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially. The therapeutic potential of novel synthetic units is huge, […]

The 3rd Targeted Radiopharmaceuticals (TRP) Summit returns at a crucial time for the entire industry. Spurred on by positive Phase III VISION trial data, there has been huge research investment, on both sides of the Atlantic, on how to deliver radiation therapy directly and specifically to tumours. For the 2021 edition of this conference, there will be the opportunity to […]

Indian Pharma Expo (IPE) will provide an opportunity for the participating companies to display their products & services to the gamut of visitors, globally from pharma and healthcare industries. The 2-day expo will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries. IPE is one stop juncture to all those who […]